| ID Source | ID |
|---|---|
| PubMed CID | 161272 |
| MeSH ID | M0090882 |
| Synonym |
|---|
| deoxyadenylyl-3'5'-deoxythymidylate |
| adenosine, thymidylyl-(3'-5')-2'-deoxy- |
| d(tpa) |
| d(at) |
| dtl-dad |
| deoxyadenylyl-3'.5'-deoxythymidylic acid |
| d(a-t) |
| 2'-deoxythymidylyl-(3'-5')-2'-deoxyadenosine |
| (dapt) |
| 19192-40-6 |
| ta(asterisk) |
| [(2r,3s,5r)-5-(6-aminopurin-9-yl)-3-hydroxyoxolan-2-yl]methyl [(2r,3r,5s)-3-(hydroxymethyl)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl] hydrogen phosphate |
| 9-[2-deoxy-5-o-(hydroxy{[3-(hydroxymethyl)-5-(4-hydroxy-5-methyl-2-oxopyrimidin-1(2h)-yl)oxolan-2-yl]oxy}phosphoryl)pentofuranosyl]-9h-purin-6-amine |
| DTXSID20940833 |
| 2/'-deoxythymidylyl-(3/'-5/')-2/'-deoxyadenosine |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (12.50) | 18.7374 |
| 1990's | 10 (31.25) | 18.2507 |
| 2000's | 3 (9.38) | 29.6817 |
| 2010's | 5 (15.63) | 24.3611 |
| 2020's | 10 (31.25) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 2 (6.25%) | 5.53% |
| Reviews | 1 (3.13%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 1 (3.13%) | 0.25% |
| Other | 28 (87.50%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Gamma-Secretase Inhibitor (DAPT), a potential therapeutic target drug, caused neurotoxicity in planarian regeneration by inhibiting Notch signaling pathway. The Science of the total environment, Aug-10, Volume: 781 | 2021 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |
| Article | Year |
|---|---|
| Adherence and persistence analysis in patients treated with double antiplatelet therapy (DAPT) at two years in real life. Patient education and counseling, Volume: 104, Issue: 8 | 2021 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |